HillA Bradford.. The clinical trial.Br Med Bull1951; 7: 278–82.
2.
HillA Bradford.. The clinical trial.N Engl J Med1952; 247: 113–19.
3.
CochraneAL. Effectiveness and Efficiency: Random Reflections on Health Services.London: Nuffield Provincial Hospitals Trust,1972.
4.
Medical Research Council.Streptomycin treatment of pulmonary tuberculosis.BMJ1948; ii: 769–82.
5.
CochraneAL. 1931–1971: a critical review, with particular reference to the medical profession. In: Medicines for the Year 2000.London: Office of Health Economics,1979: 1–11.
6.
MulrowCD. The medical review article: state of the science.An Intern Med1987; 106: 485–8.
7.
OxmanAD, GuvattGH. Guidelines for reading literature reviews.Can Med Assoc J1988; 138: 697–703.
8.
ChalmersI.Improving the quality and dissemination of reviews of clinical research. In: LockS ed. The Future of Medical Journals: In Commemoration of 150 Years of the British Medical Journal.London: British Medical Journal,1991: 127–46.
9.
CochraneAL. Foreword. In: ChalmersI, EnkinM, KeirseM.J.N.C. eds. Effective Care in Pregnancy and Childbirth.Oxford: Oxford University Press,1989.
10.
PeckhamM.Research and development for the National Health Service.Lancet1991; 338: 367–71.
ChalmersI, DickersinK, ChalmersTC. Getting to grips with Archie Cochrane's agenda.BMJ1992; 305: 786–8.
13.
ChalmersI.The Cochrane Collaboration: preparing, maintaining and disseminating systematic reviews of the effects of health care. In: Warren KS, Mosteller F, eds. Doing more good than harm: the evaluation of health care interventions.Ann NY Acad Sci1993; 703: 156–63.
14.
StewartLA, ClarkeMJ, on behalf of the Cochrane Working Group on Meta-analysis using Individual Patient Data. Practical methodology of meta-analyses (overviews) using updated individual patient data.Stat Med1995; 14: 2057–79.
15.
ChalmersI, SackettD, SilagyC.The Cochrane Collaboration. In: MaynardA, ChalmersI eds. Non-random Reflections on Health Services Research: on the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency.London: BMJ Books,1997: 231–49.
16.
VandenbrouckeJP. A short note on the history of the randomized controlled trial.J Chron Dis1987; 40: 985–7.
17.
Therapeutic Trials Committee of the Medical Research Council.The serum treatment of lobar pneumonia.BMJ1934; 1: 241–5.
18.
HillA Bradford.. Principles of medical statistics XV.Lancet1937; 1: 883–5.
19.
HillA Bradford.. Memories of the British Streptomycin Trial in Tuberculosis.Cont Clin Trials1990; 11: 77–9.
20.
ArmitageP.Bradford Hill and the randomized controlled trial.Pharm Med1992; 6: 23–37.
21.
ChalmersTC, CelanoP, SacksHS, SmithH.Bias in treatment assignment in controlled clinical trials.N Eng J Med1983; 309: 1358–61.
22.
SchulzKF, ChalmersI, HayesRJ, AltmanDG. Empirical evidence of bias: dimensions of methodological quality associated with estimates of treatment effects in controlled trials.JAMA1995; 273: 408–12.
23.
BlackN.Why we need observational studies to evaluate the effectiveness of health care.BMJ1996; 312: 1215–18.
24.
KleijnenJ, GotzscheP, KunzRH, OxmanAD, ChalmersI.So what's so special about randomisation? In: MaynardA, ChalmersI eds. Non-random Reflections on Health Services Research: on the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency.London: BMJ Books,1997: 93–106.
25.
SchulzK.Subverting randomization in controlled rials.JAMA1995; 274: 1456–8.
26.
DickersinK.Establishing and maintaining an international register of RCTs. In: SackettD, OxmanA eds. Cochrane Collaboration Handbook, Oxford: Cochrane Collaboration,1994.
27.
KorenG, GrahamK, ShearH, EinarsonT.Bias against the null hypothesis: the reproductive hazards of cocaine.Lancet1989; ii: 1440–2.
SimesRJ, SternJ, GhersiD.The importance of prospectively registering trials: evidence of publication bias from a cohort study of research protocols.BMJ (in press).
30.
MahoneyMJ. Bias, controversy, and abuse in the study of the scientific publication system.Sci Tech Hum Values1990; 15: 50.
31.
SchererRW, DickersinK, LangenbergP.Full publication of results initially presented in abstracts.JAMA1994; 272: 158–62.
32.
SimesJ.Publication bias: the case for an international registry of clinical trials.J Clin Oncol1986; 4: 1529–41.
EggerM.Language reporting bias among German-speaking authors of reports of controlled trials.Lancet (in press).
35.
GøtzschePC. Reference bias in reports of drug trials.BMJ1987; 295: 654–6.
36.
ChalmersI, HetheringtonJ, NewdickM, MutchL, GrantA, EnkinM, EnkinE, DickersinK.The Oxford Database of Perinatal Trials: developing a register of published reports of controlled trials.Controlled Clin Trials1986; 7: 306–24.
37.
ChalmersI.Evaluating the effects of care during pregnancy and childbirth. In: ChalmersI, EnkinM, KeirseM.J.N.C. eds. Effective Care in Pregnancy and Childbirth.Oxford: Oxford University Press,1989: 3–38.
38.
HetheringtonJ, DickersinK, ChalmersI, MeinertCL. Retrospective and prospective identification of unpublished controlled trials: lessons from a survey of obstetricians and pediatricians.Pediatrics1989; 84: 374–80.
39.
McDonaldSJ, LefebvreC, ClarkeMJ. Identifying reports of controlled trials in the BMJ and the Lancet.BMJ1996; 313: 1116–17.
40.
ChalmersI, HetheringtonJ, ElbourneD, KeirseM.J.N.C., EnkinM.Materials and methods used in synthesizing evidence to evaluate the effects of care during pregnancy and childbirth. In: ChalmersI, EnkinM, KeirseM.J.N.C. eds. Effective Care in Pregnancy and Childbirth.Oxford: Oxford University Press,1989: 39–65.
41.
ChalmersI.On applying overviews and meta-analyses at the bedside: comments on David Sackett's paper.J Clin Epidemiol1995; 48: 67–70.
42.
Cochrane Collaboration on Effective Professional Practice.Module in The Cochrane Library [database on disk and CD-ROM]. The Cochrane Collaboration; Issue 2.Oxford: Update Software; 1997. Updated quarterly.
43.
OlliaroP, MussanoP.Amodiaquine for the treatment of malaria. In: GarnerP, GelbandH, OlliaroP, SalinasR, VolminkJ, WilkinsonD, OlliaroP, MussanoP In: Amodiaquine for the treatment of malaria. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D. D. Amodiaquine for the treatment of malaria. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D. D. Infectious Diseases Module of The Cochrane Database of Systematic Reviews. Available in The Cochrane Library [database on disk and CD-ROM]. The Cochrane Collaboration; Issue 2. Oxford: Update Software; 1997. Updated quarterly.
44.
OakleyA, FullertonD.The lamp-post of research: support or illumination? The case for and against randomised controlled trials. In: OakleyA, RobertsH, eds Evaluating Social Interventions.Ilford: Barnardos, 1996: 4–38.
45.
MacdonaldG.Social work: beyond control? In: MaynardA, ChalmersI eds. Non-random Reflections on Health Services Research: on the 2Sth Anniversary of Archie Cochrane's Effectiveness and Efficiency.London: BMJ Books,1997: 122–46.
46.
ChalmersI.What is the prior probability of a proposed new treatment being superior to established treatments?BMJ1997; 314: 74–5.
47.
Eclampsia Trial Collaborative Group.Which anticonvulsant for women with eclampsia?Lancet1995; 345: 1455–63.
48.
SoaresK, McGrathJ, AdamsC.Evidence and tardive dyskinesia.Lancet1996; 347: 1696–7.
49.
AltmanDG. The scandal of poor medical research.BMJ1994; 308: 283–4.
50.
SpitzerWO, ed. The Potsdam International Consultation on Metaanalysis.J Clin Epidemiol1995; 48: 1–172.
51.
ShapiroS.Is meta-analysis a valid approach to the evaluation of small effects in observational studies?J Clin Epidemiol1997; 50: 223–9.
52.
FeinsteinAR. Meta-analysis: statistical alchemy for the 21st century.J Clin Epidemiol1995; 48: 71–9.
53.
HorwitzRI, FeinsteinAR. Improved observational method for studying therapeutic efficacy: suggestive evidence that lidocaine prophylaxis prevents death in acute myocardial infarction.JAMA1981; 246: 2455–59.
54.
MooreT.Deadly Medicine.New York: Simon and Schuster, 1995.
55.
HineLK, LairdN, HewittP, ChalmersTC. Meta-analytic evidence against prophylactic use of lidocaine in acute myocardial infarction.Arch Intern Med1989; 149: 2694–8.
56.
Cardiac Arrhythmia Suppression Trial Investigators.Preliminary report: Effect of encainide and flecainide on mortality in a randomized trial of arrhythmia suppression after myocardial infarction.N Engl J Med1989; 321: 406–12.
57.
Cardiac Arrhythmia Suppression Trial II Investigators. Effect of antiarrhythmic agent moricizine on survival after myocardial infarction.N Engl J Med1992; 327: 227–33.
58.
SusserM.Causal thinking in practice: strengths and weaknesses of the clinical vantage point.Pediatrics1984; 74: 842–9.
59.
VolminkJ, GarnerP.Promoting adherence to tuberculosis treatment. In: GarnerP, GelbandH, OlliaroP, SalinasR, VolminkJ, WilkinsonD, VolminkJ, GarnerP, In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D. J, Garner P. Promoting adherence to tuberculosis treatment. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D. D. Promoting adherence to tuberculosis treatment. In: Garner P, Gelband H, Olliaro P, Salinas R, Volmink J, Wilkinson D. D. Infectious Diseases Module of The Cochrane Database of Systematic Reviews. Available in The Cochrane Library [database on disk and CD-ROM]. The Cochrane Collaboration; Issue 2. Oxford: Update Software; 1997. Updated quarterly.
60.
ChalmersI.What do I want from health research and researchers when I am a patient?BMJ1995; 310: 1315–18.
61.
HartJT. Response rates in South Wales 1950–96: changing requirement for mass participation in human research. In: MaynardA, ChalmersI eds. Non-random Reflections on Health Services Research: on the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency.London: BMJ Books,1997: 31–57.
62.
OliverS.Exploring lay perspectives on questions of effectiveness. In: MaynardA, ChalmersI eds. Non-random Reflections on Health Services Research: on the 25th Anniversary of Archie Cochrane's Effectiveness and Efficiency.London: BMJ Books,1997: 272–91.
63.
ChalmersTC. In: Warren KS, Mosteller F, eds. Doing more good than harm: the evaluation of health care interventions.Ann NY Acad Sci1993; 703: 122.
64.
ChalmersI, SilvermanWA. Professional and public double standards on clinical experimentation.Controlled Clin Trials1987; 388: 91.
65.
DoyalL.Journals should not publish research to which patients have not given fully informed consent—with three exceptions.BMJ1997; 314: 1107–11.
66.
PappworthMH. Human guinea pigs: a history.BMJ1990; 301: 1456–60.
67.
ChalmersI.Medical experimentation.World Med1978 April 5: 18.
68.
ChalmersI.Human guinea pigs.BMJ1991; 302: 411.
69.
HillA Bradford.. Medical ethics and controlled trials.BMJ1963; 1: 1043–9.